GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 32 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,465,000 | +7.7% | 1,972,056 | 0.0% | 0.26% | -2.3% |
| Q4 2021 | $2,288,000 | -39.6% | 1,972,056 | 0.0% | 0.26% | -43.0% |
| Q3 2021 | $3,786,000 | -18.0% | 1,972,056 | 0.0% | 0.46% | -13.8% |
| Q2 2021 | $4,615,000 | -13.6% | 1,972,056 | 0.0% | 0.54% | -2.0% |
| Q1 2021 | $5,344,000 | +12.0% | 1,972,056 | 0.0% | 0.55% | +5.8% |
| Q4 2020 | $4,772,000 | +192.9% | 1,972,056 | +177.1% | 0.52% | +182.0% |
| Q3 2020 | $1,629,000 | -0.5% | 711,552 | 0.0% | 0.18% | +22.8% |
| Q2 2020 | $1,637,000 | +33.7% | 711,552 | 0.0% | 0.15% | -33.5% |
| Q1 2020 | $1,224,000 | -19.3% | 711,552 | -2.9% | 0.22% | -2.2% |
| Q4 2019 | $1,517,000 | -23.8% | 733,050 | +6.8% | 0.23% | -2.6% |
| Q3 2019 | $1,990,000 | -23.8% | 686,222 | +3.0% | 0.24% | -8.6% |
| Q2 2019 | $2,612,000 | – | 666,222 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,225,676 | $12,428,000 | 0.65% |
| FNY Investment Advisers, LLC | 300,000 | $516,000 | 0.39% |
| DAFNA Capital Management LLC | 542,564 | $933,000 | 0.39% |
| Polaris Venture Management Co. V, L.L.C. | 246,078 | $423,000 | 0.38% |
| BVF INC/IL | 2,100,305 | $3,613,000 | 0.34% |
| SABBY MANAGEMENT, LLC | 440,274 | $757,000 | 0.32% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 711,552 | $1,224,000 | 0.22% |
| Endurant Capital Management LP | 264,307 | $455,000 | 0.21% |
| Johnson & Johnson Innovation - JJDC, Inc. | 143,964 | $248,000 | 0.14% |
| Alyeska Investment Group, L.P. | 1,497,500 | $2,576,000 | 0.05% |